Northwest Biotherapeutics (NWBO) EPS (Weighted Average and Diluted): 2009-2025
Historic EPS (Weighted Average and Diluted) for Northwest Biotherapeutics (NWBO) over the last 11 years, with Sep 2025 value amounting to -$0.02.
- Northwest Biotherapeutics' EPS (Weighted Average and Diluted) changed negligibly% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.06, marking a year-over-year increase of 14.29%. This contributed to the annual value of -$0.07 for FY2024, which is 16.67% down from last year.
- According to the latest figures from Q3 2025, Northwest Biotherapeutics' EPS (Weighted Average and Diluted) is -$0.02, which was down 100.00% from -$0.01 recorded in Q2 2025.
- Over the past 5 years, Northwest Biotherapeutics' EPS (Weighted Average and Diluted) peaked at -$0.01 during Q4 2023, and registered a low of -$4.94 during Q1 2021.
- For the 3-year period, Northwest Biotherapeutics' EPS (Weighted Average and Diluted) averaged around -$0.02, with its median value being -$0.02 (2025).
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 222.06% in 2021, then spiked by 99.80% in 2022.
- Northwest Biotherapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.02 in 2021, then dropped by 0.00% to -$0.02 in 2022, then spiked by 50.00% to -$0.01 in 2023, then crashed by 100.00% to -$0.02 in 2024, then remained steady at -$0.02 in 2025.
- Its last three reported values are -$0.02 in Q3 2025, -$0.01 for Q2 2025, and -$0.01 during Q1 2025.